EMV Capital

EMV Capital plc is a London-listed (ticker ‘EMVC’) deep tech and life sciences venture capital investment group, with an international portfolio of high-growth companies. EMV Capital’s core sector focuses are industrial technology, healthcare and sustainability, with the underpinning thesis being strong and defensible intellectual property.

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, EMV Capital invests in, manages and strengthens early stage IP-rich companies.

By generally taking larger stakes along with board representation on many of their investee companies, EMV Capital is able to drive shareholder value and returns through its highly active management approach, hand-in-hand with its Value Creation Services practice.

EMVC typically invests at the Seed to pre-Series A level with the intention of supporting those companies as they grow and evolve, including in their future funding needs. 

Critically, EMV Capital is a co-investor; of the £100m assets under management, over £40m is EMV Capital’s direct holdings, with the remaining coming through the EIS co-investment practice and the recently acquired Cambridge-focused fund Martlet Capital, evidencing significant “skin in the game”.

To follow EMV Capital’s recent news, click here, or to learn more about the experienced team at EMV Capital, click here.